Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cornea | 24 | 2022 | 1316 | 2.990 |
Why?
|
Burns, Chemical | 9 | 2020 | 123 | 2.810 |
Why?
|
Corneal Diseases | 16 | 2022 | 535 | 2.510 |
Why?
|
Eye Burns | 7 | 2020 | 64 | 2.290 |
Why?
|
Artificial Organs | 9 | 2020 | 149 | 2.090 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2021 | 115 | 1.970 |
Why?
|
Eye Injuries | 3 | 2023 | 228 | 1.700 |
Why?
|
Retina | 8 | 2020 | 2657 | 1.570 |
Why?
|
Prostheses and Implants | 17 | 2023 | 1273 | 1.480 |
Why?
|
Microglia | 5 | 2021 | 1372 | 1.420 |
Why?
|
Monocytes | 5 | 2023 | 2595 | 1.410 |
Why?
|
Retinal Diseases | 6 | 2019 | 709 | 1.350 |
Why?
|
Neuroglia | 3 | 2020 | 964 | 1.270 |
Why?
|
Glaucoma | 7 | 2022 | 1194 | 1.220 |
Why?
|
Intraocular Pressure | 11 | 2020 | 1304 | 1.140 |
Why?
|
Corneal Neovascularization | 3 | 2020 | 184 | 1.120 |
Why?
|
Astigmatism | 2 | 2020 | 69 | 1.090 |
Why?
|
Tumor Necrosis Factor-alpha | 9 | 2023 | 4348 | 1.000 |
Why?
|
Blepharoptosis | 3 | 2023 | 143 | 0.960 |
Why?
|
Titanium | 4 | 2020 | 490 | 0.940 |
Why?
|
Organic Chemicals | 2 | 2021 | 211 | 0.820 |
Why?
|
Keratomileusis, Laser In Situ | 3 | 2011 | 81 | 0.740 |
Why?
|
Rabbits | 8 | 2020 | 4734 | 0.730 |
Why?
|
Artificial Limbs | 1 | 2022 | 121 | 0.720 |
Why?
|
Hyperopia | 2 | 2011 | 41 | 0.720 |
Why?
|
Lasers, Excimer | 3 | 2011 | 68 | 0.720 |
Why?
|
Refractive Surgical Procedures | 1 | 2019 | 21 | 0.670 |
Why?
|
Myopia | 3 | 2011 | 254 | 0.670 |
Why?
|
Glaucoma, Angle-Closure | 2 | 2019 | 192 | 0.660 |
Why?
|
Corneal Stroma | 2 | 2011 | 166 | 0.660 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2019 | 347 | 0.660 |
Why?
|
Optic Nerve Injuries | 1 | 2018 | 150 | 0.570 |
Why?
|
Glaucoma Drainage Implants | 2 | 2019 | 107 | 0.530 |
Why?
|
Sterilization | 4 | 2021 | 133 | 0.530 |
Why?
|
Retinal Degeneration | 2 | 2018 | 413 | 0.480 |
Why?
|
Blepharoplasty | 2 | 2014 | 59 | 0.470 |
Why?
|
Macrophages | 5 | 2023 | 5772 | 0.460 |
Why?
|
Hematopoiesis | 2 | 2021 | 2058 | 0.460 |
Why?
|
Gamma Rays | 5 | 2021 | 324 | 0.450 |
Why?
|
Tonometry, Ocular | 4 | 2020 | 238 | 0.450 |
Why?
|
Prosthesis Coloring | 1 | 2013 | 29 | 0.430 |
Why?
|
Corneal Wavefront Aberration | 1 | 2013 | 7 | 0.420 |
Why?
|
Nose Deformities, Acquired | 1 | 2013 | 44 | 0.420 |
Why?
|
Aberrometry | 1 | 2013 | 8 | 0.420 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 741 | 0.420 |
Why?
|
Polymethyl Methacrylate | 4 | 2021 | 126 | 0.410 |
Why?
|
Corneal Transplantation | 3 | 2021 | 315 | 0.410 |
Why?
|
Keratoplasty, Penetrating | 4 | 2022 | 143 | 0.400 |
Why?
|
Prosthesis Implantation | 5 | 2020 | 595 | 0.400 |
Why?
|
Surgical Flaps | 2 | 2011 | 1677 | 0.390 |
Why?
|
Magnetite Nanoparticles | 1 | 2013 | 309 | 0.380 |
Why?
|
Lipectomy | 2 | 2014 | 114 | 0.370 |
Why?
|
Glaucoma, Open-Angle | 5 | 2021 | 742 | 0.370 |
Why?
|
Retinal Ganglion Cells | 5 | 2019 | 810 | 0.360 |
Why?
|
Visual Acuity | 9 | 2020 | 2708 | 0.350 |
Why?
|
Hyaluronic Acid | 1 | 2013 | 484 | 0.340 |
Why?
|
Rhinoplasty | 1 | 2013 | 241 | 0.330 |
Why?
|
Neurodegenerative Diseases | 1 | 2018 | 1087 | 0.330 |
Why?
|
Cell Adhesion | 1 | 2016 | 3089 | 0.320 |
Why?
|
Cytokines | 4 | 2021 | 7421 | 0.320 |
Why?
|
Disease Models, Animal | 7 | 2020 | 18293 | 0.290 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 2 | 2019 | 256 | 0.270 |
Why?
|
Tomography, Optical Coherence | 6 | 2020 | 2932 | 0.270 |
Why?
|
Interleukin-1beta | 4 | 2020 | 1028 | 0.260 |
Why?
|
Limbus Corneae | 2 | 2018 | 144 | 0.260 |
Why?
|
Cell Proliferation | 3 | 2016 | 10429 | 0.250 |
Why?
|
Animals | 22 | 2021 | 168764 | 0.230 |
Why?
|
Endophthalmitis | 2 | 2020 | 263 | 0.230 |
Why?
|
Epithelium, Corneal | 2 | 2017 | 246 | 0.220 |
Why?
|
Oculomotor Muscles | 2 | 2022 | 404 | 0.220 |
Why?
|
Optic Nerve Diseases | 2 | 2017 | 343 | 0.210 |
Why?
|
Optic Disk | 2 | 2017 | 421 | 0.200 |
Why?
|
Aqueous Humor | 2 | 2013 | 152 | 0.200 |
Why?
|
Endothelium, Corneal | 2 | 2016 | 212 | 0.200 |
Why?
|
Complement C5 | 1 | 2021 | 99 | 0.180 |
Why?
|
Neuroprotective Agents | 2 | 2018 | 959 | 0.180 |
Why?
|
Surface Properties | 3 | 2021 | 1151 | 0.180 |
Why?
|
Fusarium | 1 | 2020 | 50 | 0.180 |
Why?
|
Bruch Membrane | 2 | 2017 | 64 | 0.180 |
Why?
|
Mice, Inbred C57BL | 8 | 2020 | 22332 | 0.180 |
Why?
|
Descemet Stripping Endothelial Keratoplasty | 1 | 2022 | 110 | 0.170 |
Why?
|
Receptors, Chemokine | 1 | 2023 | 651 | 0.170 |
Why?
|
Sodium Hydroxide | 2 | 2017 | 37 | 0.170 |
Why?
|
Gonioscopy | 1 | 2020 | 157 | 0.170 |
Why?
|
Nerve Fibers | 2 | 2016 | 705 | 0.170 |
Why?
|
Gelatin | 1 | 2021 | 227 | 0.170 |
Why?
|
Aniridia | 1 | 2019 | 36 | 0.160 |
Why?
|
Aspergillus fumigatus | 1 | 2020 | 158 | 0.160 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 281 | 0.160 |
Why?
|
Blindness | 2 | 2020 | 586 | 0.160 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2020 | 754 | 0.150 |
Why?
|
N-Methylaspartate | 1 | 2019 | 228 | 0.150 |
Why?
|
Prosthesis Design | 3 | 2020 | 2105 | 0.150 |
Why?
|
Blood Sedimentation | 1 | 2019 | 233 | 0.150 |
Why?
|
Mice | 10 | 2020 | 81819 | 0.140 |
Why?
|
Candida albicans | 1 | 2020 | 377 | 0.140 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2018 | 93 | 0.140 |
Why?
|
Uvea | 1 | 2017 | 31 | 0.140 |
Why?
|
Alkalies | 1 | 2017 | 45 | 0.140 |
Why?
|
Disinfection | 1 | 2019 | 207 | 0.140 |
Why?
|
Humans | 44 | 2023 | 765968 | 0.140 |
Why?
|
Magnetic Field Therapy | 1 | 2017 | 27 | 0.140 |
Why?
|
Low Tension Glaucoma | 1 | 2016 | 24 | 0.130 |
Why?
|
Fibroblasts | 3 | 2021 | 4159 | 0.130 |
Why?
|
GTPase-Activating Proteins | 1 | 2019 | 465 | 0.130 |
Why?
|
Uveitis, Anterior | 1 | 2017 | 103 | 0.130 |
Why?
|
Anterior Eye Segment | 1 | 2017 | 144 | 0.130 |
Why?
|
Drug Implants | 1 | 2017 | 230 | 0.130 |
Why?
|
Posterior Eye Segment | 1 | 2016 | 18 | 0.130 |
Why?
|
Tissue Scaffolds | 2 | 2021 | 934 | 0.130 |
Why?
|
Species Specificity | 1 | 2020 | 2406 | 0.130 |
Why?
|
Electrons | 3 | 2021 | 265 | 0.120 |
Why?
|
Models, Animal | 2 | 2019 | 2120 | 0.120 |
Why?
|
Mice, Mutant Strains | 1 | 2018 | 1745 | 0.120 |
Why?
|
Antifungal Agents | 1 | 2020 | 769 | 0.120 |
Why?
|
Hemianopsia | 1 | 2017 | 121 | 0.120 |
Why?
|
Antibiotic Prophylaxis | 1 | 2020 | 644 | 0.120 |
Why?
|
Complement Pathway, Alternative | 1 | 2015 | 106 | 0.120 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2017 | 2477 | 0.120 |
Why?
|
Phagocytosis | 1 | 2020 | 1520 | 0.120 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 3807 | 0.110 |
Why?
|
Filtering Surgery | 1 | 2014 | 34 | 0.110 |
Why?
|
Cicatrix | 1 | 2020 | 798 | 0.110 |
Why?
|
Materials Testing | 2 | 2018 | 868 | 0.110 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2015 | 203 | 0.110 |
Why?
|
Inflammasomes | 1 | 2019 | 543 | 0.110 |
Why?
|
Cogan Syndrome | 1 | 2013 | 10 | 0.110 |
Why?
|
Biocompatible Materials | 3 | 2021 | 1682 | 0.110 |
Why?
|
Conjunctiva | 1 | 2017 | 477 | 0.100 |
Why?
|
Delayed-Action Preparations | 1 | 2017 | 967 | 0.100 |
Why?
|
Electrochemical Techniques | 1 | 2013 | 90 | 0.100 |
Why?
|
Vitreous Body | 1 | 2015 | 400 | 0.100 |
Why?
|
Apraxias | 1 | 2013 | 58 | 0.100 |
Why?
|
X-Ray Diffraction | 1 | 2013 | 411 | 0.100 |
Why?
|
Corneal Opacity | 1 | 2012 | 52 | 0.100 |
Why?
|
Antigens, CD | 2 | 2020 | 4025 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2022 | 39193 | 0.100 |
Why?
|
Trabecular Meshwork | 1 | 2012 | 101 | 0.100 |
Why?
|
Injections, Subcutaneous | 1 | 2013 | 682 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 1333 | 0.100 |
Why?
|
Male | 22 | 2020 | 363698 | 0.100 |
Why?
|
Retinoblastoma | 1 | 2014 | 316 | 0.100 |
Why?
|
Female | 21 | 2020 | 396112 | 0.100 |
Why?
|
Esthetics | 1 | 2013 | 326 | 0.090 |
Why?
|
Nerve Degeneration | 1 | 2016 | 748 | 0.090 |
Why?
|
Bioprosthesis | 1 | 2016 | 589 | 0.090 |
Why?
|
Tissue Engineering | 1 | 2021 | 1855 | 0.090 |
Why?
|
Corneal Topography | 1 | 2011 | 69 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2022 | 5302 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2020 | 3513 | 0.090 |
Why?
|
Refractive Errors | 1 | 2013 | 148 | 0.090 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2218 | 0.090 |
Why?
|
Intravitreal Injections | 1 | 2013 | 401 | 0.090 |
Why?
|
Leptin | 1 | 2019 | 1596 | 0.090 |
Why?
|
Calibration | 1 | 2013 | 814 | 0.090 |
Why?
|
Visual Fields | 1 | 2017 | 1063 | 0.090 |
Why?
|
Transplantation Immunology | 1 | 2012 | 541 | 0.090 |
Why?
|
Postoperative Complications | 4 | 2019 | 15747 | 0.090 |
Why?
|
Scanning Laser Polarimetry | 1 | 2010 | 5 | 0.090 |
Why?
|
Refraction, Ocular | 1 | 2011 | 188 | 0.090 |
Why?
|
Neuronal Plasticity | 1 | 2018 | 1445 | 0.080 |
Why?
|
Microscopy, Confocal | 1 | 2016 | 1966 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1884 | 0.080 |
Why?
|
Eye Infections, Bacterial | 1 | 2013 | 239 | 0.080 |
Why?
|
Photorefractive Keratectomy | 1 | 2010 | 34 | 0.080 |
Why?
|
Neovascularization, Pathologic | 1 | 2019 | 2631 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2226 | 0.080 |
Why?
|
Eye Diseases | 1 | 2015 | 659 | 0.080 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 26318 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1602 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2207 | 0.080 |
Why?
|
Blotting, Western | 1 | 2016 | 5020 | 0.080 |
Why?
|
Extracellular Matrix | 1 | 2016 | 1727 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1808 | 0.070 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2010 | 252 | 0.070 |
Why?
|
Middle Aged | 15 | 2020 | 223009 | 0.070 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9550 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2017 | 1365 | 0.070 |
Why?
|
Eyelids | 2 | 2023 | 279 | 0.070 |
Why?
|
Metformin | 1 | 2014 | 904 | 0.070 |
Why?
|
Cell Movement | 1 | 2018 | 5194 | 0.070 |
Why?
|
Retrospective Studies | 9 | 2022 | 81514 | 0.070 |
Why?
|
Swine | 3 | 2021 | 5988 | 0.060 |
Why?
|
In Situ Nick-End Labeling | 2 | 2019 | 610 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2016 | 20124 | 0.060 |
Why?
|
Stem Cells | 1 | 2017 | 3540 | 0.060 |
Why?
|
Aged | 13 | 2020 | 171117 | 0.060 |
Why?
|
Patient Satisfaction | 2 | 2014 | 3475 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4034 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2268 | 0.060 |
Why?
|
Drug Combinations | 2 | 2020 | 2077 | 0.050 |
Why?
|
Apoptosis | 2 | 2017 | 9514 | 0.050 |
Why?
|
Inflammation | 2 | 2021 | 10850 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2019 | 18973 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2014 | 3312 | 0.050 |
Why?
|
Cell Line | 1 | 2016 | 15543 | 0.050 |
Why?
|
Cell Death | 2 | 2019 | 1679 | 0.050 |
Why?
|
Mice, Knockout | 1 | 2017 | 14448 | 0.050 |
Why?
|
Young Adult | 6 | 2020 | 59889 | 0.050 |
Why?
|
Thermogravimetry | 1 | 2021 | 7 | 0.050 |
Why?
|
Methacrylates | 1 | 2021 | 109 | 0.050 |
Why?
|
Calorimetry, Differential Scanning | 1 | 2021 | 92 | 0.050 |
Why?
|
Epoxy Compounds | 1 | 2021 | 136 | 0.050 |
Why?
|
Polymyxin B | 1 | 2020 | 43 | 0.050 |
Why?
|
Mice, Inbred BALB C | 3 | 2016 | 6220 | 0.050 |
Why?
|
Pyrrolidinones | 1 | 2021 | 116 | 0.050 |
Why?
|
Benzalkonium Compounds | 1 | 2020 | 22 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2018 | 11641 | 0.050 |
Why?
|
Adult | 12 | 2020 | 223044 | 0.040 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2021 | 157 | 0.040 |
Why?
|
Trimethoprim | 1 | 2020 | 79 | 0.040 |
Why?
|
Contact Lenses, Hydrophilic | 1 | 2020 | 53 | 0.040 |
Why?
|
Microscopy, Atomic Force | 1 | 2021 | 250 | 0.040 |
Why?
|
Eye Infections, Fungal | 1 | 2020 | 99 | 0.040 |
Why?
|
Complement Activation | 1 | 2021 | 431 | 0.040 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2019 | 146 | 0.040 |
Why?
|
Ultrasonography | 1 | 2011 | 5993 | 0.040 |
Why?
|
Laminin | 1 | 2019 | 404 | 0.040 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2019 | 594 | 0.040 |
Why?
|
Postoperative Period | 2 | 2014 | 1816 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9249 | 0.030 |
Why?
|
Prospective Studies | 4 | 2017 | 54802 | 0.030 |
Why?
|
Cost Control | 1 | 2019 | 624 | 0.030 |
Why?
|
Oculomotor Nerve Diseases | 1 | 2017 | 53 | 0.030 |
Why?
|
Caspases | 1 | 2019 | 880 | 0.030 |
Why?
|
Proteoglycans | 1 | 2019 | 793 | 0.030 |
Why?
|
Exotropia | 1 | 2017 | 64 | 0.030 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2019 | 660 | 0.030 |
Why?
|
Transplantation, Isogeneic | 1 | 2016 | 251 | 0.030 |
Why?
|
Hydrogels | 1 | 2021 | 728 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2021 | 1668 | 0.030 |
Why?
|
Transplantation, Homologous | 2 | 2016 | 4860 | 0.030 |
Why?
|
Lasers | 1 | 2019 | 951 | 0.030 |
Why?
|
Visual Field Tests | 1 | 2017 | 415 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2020 | 1191 | 0.030 |
Why?
|
Water | 1 | 2021 | 1417 | 0.030 |
Why?
|
Organ Preservation | 1 | 2018 | 399 | 0.030 |
Why?
|
Temperature | 1 | 2021 | 2226 | 0.030 |
Why?
|
Oligopeptides | 1 | 2019 | 1192 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2020 | 1971 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2019 | 3586 | 0.030 |
Why?
|
Imidazoles | 1 | 2019 | 1162 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 2014 | 413 | 0.030 |
Why?
|
Rhytidoplasty | 1 | 2014 | 72 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2019 | 12768 | 0.030 |
Why?
|
Conjunctivitis | 1 | 2014 | 153 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2021 | 2394 | 0.030 |
Why?
|
Diplopia | 1 | 2014 | 217 | 0.030 |
Why?
|
Triamcinolone Acetonide | 1 | 2013 | 105 | 0.020 |
Why?
|
Aptamers, Nucleotide | 1 | 2013 | 163 | 0.020 |
Why?
|
Preoperative Period | 1 | 2014 | 566 | 0.020 |
Why?
|
Exfoliation Syndrome | 1 | 2012 | 113 | 0.020 |
Why?
|
Indoles | 1 | 2019 | 1839 | 0.020 |
Why?
|
Collagen | 1 | 2019 | 2618 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2014 | 595 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3737 | 0.020 |
Why?
|
Orbit | 1 | 2014 | 456 | 0.020 |
Why?
|
Incidence | 2 | 2022 | 21480 | 0.020 |
Why?
|
Isoantigens | 1 | 2012 | 562 | 0.020 |
Why?
|
Edema | 1 | 2014 | 760 | 0.020 |
Why?
|
Adolescent | 3 | 2014 | 88835 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2016 | 59489 | 0.020 |
Why?
|
Axons | 1 | 2016 | 1682 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2012 | 975 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6322 | 0.020 |
Why?
|
Autophagy | 1 | 2014 | 1351 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 3608 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2056 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15842 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7584 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2013 | 2056 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5747 | 0.010 |
Why?
|
Chronic Disease | 1 | 2017 | 9347 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2780 | 0.010 |
Why?
|
Acute Disease | 1 | 2013 | 7232 | 0.010 |
Why?
|
Graft Survival | 1 | 2012 | 3890 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2012 | 3564 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8875 | 0.010 |
Why?
|
Graft Rejection | 1 | 2012 | 4499 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15880 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2016 | 22223 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2014 | 8611 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13632 | 0.010 |
Why?
|
Risk Factors | 1 | 2022 | 74840 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 7478 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 65188 | 0.010 |
Why?
|